NASDAQ | ETF
The fund invests more than 80% of its total assets in the securities of the underlying index.
The underlying index is designed to provide exposure to exchange-listed companies in developed markets that facilitate the demographic trend of longer average life spans and the aging of the global population, including but not limited to companies involved in biotechnology, medical devices, pharmaceuticals, senior living facilities and specialized health care services.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 5.17% |
| 4519 | Chugai Pharmaceutical Co. Ltd. | Healthcare | Drug Manufacturers - General | 4.91% |
| 0QIU | Novo Nordisk A/S Class B | 3.89% | ||
| NOVO-B | Novo Nordisk A/S | Healthcare | Biotechnology | 3.76% |
| WELL | Welltower Inc | Real Estate | REIT - Healthcare Facilities | 3.73% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 3.68% |
| BSX | Boston Scientific Corp | Healthcare | Medical Devices | 3.51% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 3.39% |
| ALC | Alcon AG | Healthcare | Medical Instruments & Supplies | 3.36% |
| DXCM | DexCom Inc | Healthcare | Medical Devices | 3.24% |
| SYK | Stryker Corporation | Healthcare | Medical Devices | 3.24% |
| MDT | Medtronic PLC | Healthcare | Medical Devices | 3.23% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 3.01% |
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 2.95% |
| AZN | AstraZeneca PLC ADR | Healthcare | Drug Manufacturers - General | 2.80% |
| EW | Edwards Lifesciences Corp | Healthcare | Medical Devices | 2.64% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 2.59% |
| RO | Roche Holding AG | Healthcare | Drug Manufacturers - General | 2.39% |
| BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 2.15% |
| 4543 | Terumo Corp. | Healthcare | Medical Instruments & Supplies | 1.82% |